Roche Diagnostics Australia

The Value of Diagnostics

Small details tell a big story.

Whether it’s infectious diseases, cancer or other serious health threats, the quest for solutions to healthcare’s greatest challenges starts with – and depends on – diagnostics. 

 

Latest News

Patient Hugging Carer
Sustainability

Roche 125-Year Anniversary Health Charity Grants

As part of Roche’s 125-Year Anniversary 'Celebrate Life' campaign to commemorate the company’s history and lasting legacy, Roche Australia is pleased to launch the 125-Year Anniversary Health Charity Grants – an initiative designed to help improve the health outcomes of Australians.

Read More
Cervical Cancer Roche
News

Australia One of First to Offer Game-Changing Self-Collection Option For Cervical Cancer Screening 

From 1st July all Australian women aged 25 to 74 years of age will be among the first in the world to have the option to take a self-collected – a move that is expected to increase screening participation rates to help eliminate cervical cancer by 2030.

Learn More
Through Precision Oncology Screening Platform Enabling Clinical Trials
News

Precision Oncology Screening Platform Enabling Clinical Trials

Roche Australia, in partnership with the Australian Federal Government, Omico, and other partners, has announced an agreement to jointly fund an important new initiative aimed at improving access to clinical trials for Australians diagnosed with cancer.

Learn More

 

SARS-CoV-2 Rapid Antigen
Test Solutions

 

Reliable SARS-CoV-2 antigen test results in just 15 minutes.

 

Rapid antigen testing continues to play a critical role in managing the COVID-19 pandemic and forms part of our commitment to keeping Aussies safe.

 

For more information visit:

COVID-19 Rapid Antigen Self-Test (for home use)

COVID-19 Rapid Antigen Point of Care (POC) tests (for professional use)

rapid-antigen-test

The COVID-19 Rapid Antigen Self-Test (for home use) is intended for unsupervised testing in the home or other environment.

The COVID-19 Rapid Antigen Point of Care (POC) tests (for professional use) are intended for use at the point of care and must be used by relevant practitioners, or persons under their supervision, who are trained in the correct use of the goods and the interpretation of the test results. These tests must not be supplied for the purpose of self-testing.

Negative test results do not exclude infection with COVID-19 (so face masks, social distancing and good hygiene practice must be maintained).

Follow current government health messaging regarding polymerase chain reaction (PCR) testing requirements.

 

Inside Roche

Roche Diagnostics

Roche Diagnostics

At Roche Diagnostics, we develop and integrate diagnostic solutions that address the challenges of today and anticipate the needs of tomorrow.

Learn More
Roche Pharma

Roche Pharmaceuticals

At Roche Pharmaceuticals, we focus on finding new medicines that help patients live longer, better lives and evolve the practice of medicine.

Learn More
Roche Diabetes Care

Roche Diabetes Care

Roche Diabetes Care supports people with diabetes to help them achieve more time in their target range and experience true relief from the daily therapy routines.

Learn More

09441751001_00000000_02